| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/21/2005 | WO2004072256A3 Variants of cytochrome c and methods of diagnostics of thrombocytopenia |
| 04/21/2005 | WO2004064739A3 Substrate detection assay |
| 04/21/2005 | WO2004060316A3 Irs modulators |
| 04/21/2005 | WO2004048514A3 Methods for analyzing a nucleic acid |
| 04/21/2005 | WO2004045543A3 Functional and hyperfunctional sirna |
| 04/21/2005 | WO2004041156A3 Method for determining sensitivity to a bacteriophage |
| 04/21/2005 | WO2004040252A3 Molecules and methods using same for measuring non-transferrin bound iron |
| 04/21/2005 | WO2004038380A3 Screening methods for identification of efficient pre-trans-splicing molecules |
| 04/21/2005 | WO2004035828A3 Diagnostic and therapeutic means for kidney stone related pathologies |
| 04/21/2005 | WO2004031142A3 Inhibition of metallo-beta-lactamase |
| 04/21/2005 | WO2004029852A3 Method, computer program product and system for microarray cross-hybridisation detection |
| 04/21/2005 | WO2004021978A3 Antisense modulation of endothelial specific molecule 1 expression |
| 04/21/2005 | WO2004005886A3 Kits and methods for assessing cardiovascular health |
| 04/21/2005 | WO2003107270A3 Metabolic phenotyping |
| 04/21/2005 | WO2003091698A3 Cetp genetic markers for statin-specific changes in hdl cholesterol |
| 04/21/2005 | WO2003087772A3 Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells |
| 04/21/2005 | WO2003048349A8 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances |
| 04/21/2005 | WO2002099053A3 Slc22as as modifiers of the p53 pathway and methods of use |
| 04/21/2005 | WO2002092842A3 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | US20050086711 Transgenic animals and methods for screening for anti-amyloidogenic agents and agents for treating neurodegenerative disease |
| 04/21/2005 | US20050086017 Methods for operating mass spectrometry (MS) instrument systems |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050084983 Urine test for the diagnosis of prion diseases |
| 04/21/2005 | US20050084971 Using trehalose metabolism as reporter function to identify transgenic plants |
| 04/21/2005 | US20050084952 Apparatus for preparing an array of chemical compounds on the surface of a support; biochips |
| 04/21/2005 | US20050084936 Human regulatory proteins |
| 04/21/2005 | US20050084922 Fabricating reagent test strip; contacting test pad with analyte oxidizing signal producing system comprising water soluble tetrazolium salt and nitrite stabilizing agent, contact test pad to substrate, recover test strip; blood screening |
| 04/21/2005 | US20050084921 Enzyme-based system and sensor for measuring acetone |
| 04/21/2005 | US20050084920 Fluorescence assay for measuring the rate of cholesterol ester transfer |
| 04/21/2005 | US20050084914 Assays with primary cells |
| 04/21/2005 | US20050084913 Tumor antigen for use as tool in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 04/21/2005 | US20050084909 Biochip for monitoring concentration of immunoglobulin in solution; bioassay; immunoassay |
| 04/21/2005 | US20050084905 Identification of kinase inhibitors |
| 04/21/2005 | US20050084899 Compositions and methods relating to breast specific genes and proteins |
| 04/21/2005 | US20050084898 Comparative fluorescence hybridization to nucleic acid arrays |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084896 Process to study changes in gene expression in granulocytic cells |
| 04/21/2005 | US20050084894 Methods and compositions for nucleic acid analysis |
| 04/21/2005 | US20050084890 High-throughput screening assay for inhibitors of replication protein A |
| 04/21/2005 | US20050084889 Preferential display |
| 04/21/2005 | US20050084885 Modified transcription factor protein for use as tool in prevention and treatment of cell proliferative disorder |
| 04/21/2005 | US20050084883 Using insulin like growth factor binding protein expression as diagnostic/prognostic tool in detection of cell proliferative disorders |
| 04/21/2005 | US20050084882 Using interleukin specific oligonucleotides to generate diagnostic profiles for use as tools in detection of bone disorders; hormone replacement |
| 04/21/2005 | US20050084881 Electrocatalytic nucleic acid hybridization detection |
| 04/21/2005 | US20050084880 Systems and methods for diagnosing & treating psychological and behavioral conditions |
| 04/21/2005 | US20050084879 Particle agglutination detection method and device |
| 04/21/2005 | US20050084878 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment |
| 04/21/2005 | US20050084875 Molecular markers for the diagnosis of Alzheimer's disease |
| 04/21/2005 | US20050084874 Microfiltration and/or ultrafiltration process for recovery of target molecules from polydisperse liquids |
| 04/21/2005 | US20050084873 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 04/21/2005 | US20050084870 4,7-dichlorofluorescein dyes as molecular probes |
| 04/21/2005 | US20050084869 Novel composition and methods for the diagnosis of lung cancer |
| 04/21/2005 | US20050084867 Hybridization and scanning apparatus |
| 04/21/2005 | US20050084865 Bioreactor comprising electrodes and multilayered substrates for use in monitoring and analyzing biopolymer hybridization events |
| 04/21/2005 | US20050084864 Using reporter protein expression as diagnostic indicator preferential protein activity; bioassay |
| 04/21/2005 | US20050084863 Removal of nucleic acid contaminants |
| 04/21/2005 | US20050084861 Methods of detecting modification of genetic material and monitoring processes thereof |
| 04/21/2005 | US20050084860 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/21/2005 | US20050084858 Method for monitoring and prognosis of disease course of gastrointestinal tumors |
| 04/21/2005 | US20050084857 Breast tumor antigen for use as tool in diagnosis prevention and treatment of mammary gland cell proliferative disorders; antitumor agents |
| 04/21/2005 | US20050084855 Using solid support comprising immobilized locked nucleic acids or peptide nucleic acid to identify preferential particles in solution |
| 04/21/2005 | US20050084854 Viral probes for use as tools in sequencing and genotyping lymphadenopathy associated viral subtypes |
| 04/21/2005 | US20050084852 Perinucleolar compartment as a cancer marker |
| 04/21/2005 | US20050084851 Classifying preferential nucleic acids via sequencing-by-synthesis; genotyping and sequence determination |
| 04/21/2005 | US20050084850 Stromal cell protein for use as tool in stimulating blood production in patients undergoing chemotherapy |
| 04/21/2005 | US20050084849 Using single nucleotide polymorphism in nitric acid synthase gene as diagnostic tool in detection of heart, pancreatic, hypertensive, kidney and cell proliferative disorders |
| 04/21/2005 | US20050084848 Methods of using glucan synthase pathway reporter genes to screen for antifungal compounds |
| 04/21/2005 | US20050084847 Hepatitis |
| 04/21/2005 | US20050084846 Using mucin-1 expression after exposure to interferon as prognostic tool in predicting respiratory infection |
| 04/21/2005 | US20050084844 Genetic screen for bioactive peptides |
| 04/21/2005 | US20050084843 System and method for identifying proteins involved in force-initiated signal transduction |
| 04/21/2005 | US20050084841 Using antisense agents specific to immunoglobulin superfamily genes containing leucine-rich repeat as therapeutic tool in treatment of arthritis |
| 04/21/2005 | US20050084840 Method for screening drug for improving insulin resistance |
| 04/21/2005 | US20050084839 Method for selecting oocytes by using a response to LPA stimulation |
| 04/21/2005 | US20050084499 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines |
| 04/21/2005 | US20050084491 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/21/2005 | US20050084485 Clckb mutation as a diagnostic and therapeutical target |
| 04/21/2005 | US20050083078 Test key for bridge and continuity testing |
| 04/21/2005 | US20050082471 Ion beam extraction electrode; skimmer cone restricts gas pumping immediately behind skimmer cone orifice to provide a higher pressure compared to downstream; provides collisional gas volume for plasma for attenuating polyatomic and multicharged interfering ions; isotopic analysis |
| 04/21/2005 | US20050082175 Diagnosis by sensing volatile components |
| 04/21/2005 | CA2761987A1 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | CA2746552A1 Device for separating and/ analysing several molecular targets dissolved in a complex mixture |
| 04/21/2005 | CA2578473A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | CA2546730A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 04/21/2005 | CA2542860A1 Fluorescence indicator utilizing fret |
| 04/21/2005 | CA2542859A1 Molecular detection of mycobacterium avium subsp. paratuberculosis |
| 04/21/2005 | CA2542781A1 Method of classifying chemical agents and identifying cellular targets thereof |
| 04/21/2005 | CA2542608A1 Igf-i responsive gene and use thereof |
| 04/21/2005 | CA2541836A1 A diagnostic method for neonatal or infantile epilepsy syndromes |
| 04/21/2005 | CA2541804A1 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | CA2541706A1 Methods for prenatal diagnosis of chromosomal abnormalities |
| 04/21/2005 | CA2541689A1 Method for the rapid detection of micro-organisms on dna chips |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | CA2541473A1 Method and kit for assessing anxiety or disposition thereto in a subject |
| 04/21/2005 | CA2540551A1 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 04/21/2005 | CA2539795A1 Bacterial lethality test indicator and prompt response spectroscopic analyzer |
| 04/21/2005 | CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 04/21/2005 | CA2539583A1 Prebiotic effect analysis |
| 04/21/2005 | CA2539064A1 Identification of kinase inhibitors |